Oncologia

M-A | Cirurgia citorredutora secundária no câncer de ovário recorrente sensível à platina.

24 Fev, 2022 | 15:21h

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (necessário cadastro gratuito)

Conteúdos relacionados:

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.

---

Revisão das neoplasias mucinosas císticas e intraductais do trato pancreatobiliar: avanços recentes.

24 Fev, 2022 | 15:18h

A Review of Mucinous Cystic and Intraductal Neoplasms of the Pancreatobiliary Tract: Recent Advances – Archives of Pathology & Laboratory Medicine

---

Diretriz AGA sobre terapias sistêmicas para carcinoma hepatocelular.

24 Fev, 2022 | 13:42h

AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma – Gastroenterology

Comunicado de imprensa: AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma – American Gastroenterology Association

---

Atualização de diretriz ASCO | Terapia sistêmica adjuvante e radioterapia adjuvante para câncer de pulmão de não pequenas células estágios I-IIIA completamente ressecado.

24 Fev, 2022 | 13:39h

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non–Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update – Journal of Clinical Oncology

Comentário: Rapid Guideline Revises Recommendations for Adjuvant Therapy in Patients With Early-Stage Lung Cancer – ASCO Daily News

 

Comentário no Twitter

‼️ Just published in #JCO: @ASCO rapid guideline update on adjuvant systemic therapy & adjuvant radiation therapy for stage I to IIIA completely resected #NSCLC 🫁 https://t.co/OheQi7Bi97 #lcsm #radonc pic.twitter.com/Dax2orUXZy

— Journal of Clinical Oncology (@JCO_ASCO) February 15, 2022

 

---

Revisão sistemática | Paclitaxel com carboplatina 1 vez/semana vs. 1 vez a cada 3 semanas para tratamento de primeira linha em mulheres com câncer epitelial de ovário.

24 Fev, 2022 | 13:36h

Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with epithelial ovarian cancer – Cochrane Library

Resumo: Does weekly dosing of paclitaxel improve survival, compared with tri-weekly dosing of paclitaxel in the initial treatment of ovarian cancer? – Cochrane Library

---

Opinião | Controlando o braço-controle em estudos sobre câncer de próstata metastático resistente à castração: melhores ou mínimos padrões de cuidado?

24 Fev, 2022 | 13:35h

Controlling the Control Arm in Metastatic Castration-Resistant Prostate Cancer Trials: Best Standard of Care or the Minimum Standard of Care? – Journal of Clinical Oncology

---

Estudo randomizado | Comparação de 3 regimes quimioterápicos baseados em paclitaxel para pacientes com câncer esofágico de células escamosas avançado.

22 Fev, 2022 | 15:11h

Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer: A Randomized Clinical Trial – JAMA Network Open

---

Opinião clínica provisória ASCO | Teste genômico somático em pacientes com câncer avançado ou metastático.

22 Fev, 2022 | 14:40h

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion – Journal of Clinical Oncology

Comunicado de imprensa: ASCO Provisional Clinical Opinion Offers Guidance for Using and Interpreting Genomic Testing in Patients With Advanced Cancer – ASCO Daily News

---

Diretrizes IPSO de prática cirúrgica na cirurgia oncológica pediátrica.

22 Fev, 2022 | 14:38h

International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines – eCancer

---

Revisão | Tromboembolismo venoso associado a câncer.

22 Fev, 2022 | 14:37h

Cancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Infográfico: Cancer-associated venous thromboembolism – Nature Reviews Disease Primers (se o acesso a este link for pago, tente este)

Conteúdos relacionados:

NCCN Guideline: Cancer-Associated Venous Thromboembolic Disease.

ASH 2021 guidelines for prevention and treatment of venous thromboembolism in patients with cancer

Review: venous and arterial thromboembolism in patients with cancer.

Systematic Review: Does testing for cancer in people with unprovoked blood clots in the legs and lungs reduce cancer- and blood clot-related death and illness?

M-A: Extended thromboprophylaxis after hospital discharge for medically ill patients with cancer – Extended thromboprophylaxis is not associated with a reduced rate of venous thromboembolic events and is associated with increased risk of hemorrhage

Systematic review: Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

---